Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Aug 1;160(2):386–397. doi: 10.1084/jem.160.2.386

Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae

PMCID: PMC2187447  PMID: 6381634

Abstract

Monoclonal antibodies were raised against surface determinants of Streptococcus pneumoniae by hyperimmunizing X-linked immunodeficient (xid) CBA/N mice with the heat-killed rough strain R36A. 17 hybridomas produced antibody that bound intact R36A and did not cross-react with phosphocholine, an antigen common in the cell wall of all S. pneumoniae. The antibody produced by at least two of these hybridomas, Xi64 (IgM) and Xi126 (IgG2b), could protect mice from a lethal intravenous challenge of type 3 S. pneumoniae strains WU2 and A66 and of the type 2 strain D39. The minimum amount of antibody required to protect xid mice from 100 WU2 was 4.5 micrograms/mouse for Xi64 and 2.6 micrograms/mouse for Xi126,. Free phosphocholine, C-polysaccharide, and type 3 capsular polysaccharide all failed to inhibit the binding of Xi64 or Xi126 to R36A. These antibodies appeared to bind surface polypeptides, since treatment of R36A with either pepsin or trypsin, or of R36A lysate with trypsin, effectively eliminated the ability of Xi64 and Xi126 to bind antigens in these preparations. Binding studies indicated that these two antibodies recognized different epitopes that were expressed on several but not all serotypes of pneumococci.

Full Text

The Full Text of this article is available as a PDF (882.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTRIAN R., MacLEOD C. M. A type-specific protein from pneumococcus. J Exp Med. 1949 Apr 1;89(4):439–450. doi: 10.1084/jem.89.4.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson P., Smith D. H., Ingram D. L., Wilkins J., Wehrle P. F., Howie V. M. Antibody of polyribophate of Haemophilus influenzae type b in infants and children: effect of immunization with polyribophosphate. J Infect Dis. 1977 Aug;136 (Suppl):S57–S62. doi: 10.1093/infdis/136.supplement.s57. [DOI] [PubMed] [Google Scholar]
  3. Andres C. M., Maddalena A., Hudak S., Young N. M., Claflin J. L. Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families. J Exp Med. 1981 Nov 1;154(5):1584–1598. doi: 10.1084/jem.154.5.1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Askonas B. A., Williamson A. R. Dominance of a cell clone forming antibody to DNP. Nature. 1972 Aug 11;238(5363):339–341. doi: 10.1038/238339a0. [DOI] [PubMed] [Google Scholar]
  5. Au C. C., Eisenstein T. K. Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae. Infect Immun. 1981 Jan;31(1):160–168. doi: 10.1128/iai.31.1.160-168.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Austrian R. Pneumococcal vaccine: development and prospects. Am J Med. 1979 Oct;67(4):547–549. doi: 10.1016/0002-9343(79)90222-5. [DOI] [PubMed] [Google Scholar]
  7. Avery O. T., Macleod C. M., McCarty M. STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III. J Exp Med. 1944 Feb 1;79(2):137–158. doi: 10.1084/jem.79.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Braun D. G., Eichmann K., Krause R. M. Rabbit antibodies to streptococcal carbohydrates. Influence of primary and secondary immunization and of possible genetic factors on the antibody response. J Exp Med. 1969 Apr 1;129(4):809–830. doi: 10.1084/jem.129.4.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Briles D. E., Davie J. M. Clonal nature of the immune response. II. The effect of immunization on clonal commitment. J Exp Med. 1980 Jul 1;152(1):151–160. doi: 10.1084/jem.152.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Briles D. E., Nahm M., Marion T. N., Perlmutter R. M., Davie J. M. Streptococcal group A carbohydrate has properties of both a thymus-independent (TI-2) and a thymus-dependent antigen. J Immunol. 1982 May;128(5):2032–2035. [PubMed] [Google Scholar]
  11. Briles D. E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med. 1981 Mar 1;153(3):694–705. doi: 10.1084/jem.153.3.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brown A. R., DeWitt C. L., Bosma M. J., Nisonoff A. Dominance of an immune response by secondary cells: quantitation by allotype analysis. J Immunol. 1980 Jan;124(1):250–254. [PubMed] [Google Scholar]
  13. Brown E. J., Hosea S. W., Hammer C. H., Burch C. G., Frank M. M. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J Clin Invest. 1982 Jan;69(1):85–98. doi: 10.1172/JCI110444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brundish D. E., Baddiley J. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem J. 1968 Dec;110(3):573–582. doi: 10.1042/bj1100573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cowan M. J., Ammann A. J., Wara D. W., Howie V. M., Schultz L., Doyle N., Kaplan M. Pneumococcal polysaccharide immunization in infants and children. Pediatrics. 1978 Nov;62(5):721–727. [PubMed] [Google Scholar]
  16. Cramer M., Braun D. G. Immunological memory: stable IgG patterns determine in vivo responsiveness at the clonal level. Scand J Immunol. 1975;4(1):63–70. doi: 10.1111/j.1365-3083.1975.tb02600.x. [DOI] [PubMed] [Google Scholar]
  17. Douglas R. M., Paton J. C., Duncan S. J., Hansman D. J. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis. 1983 Jul;148(1):131–137. doi: 10.1093/infdis/148.1.131. [DOI] [PubMed] [Google Scholar]
  18. Dubos R. J. IMMUNIZATION OF EXPERIMENTAL ANIMALS WITH A SOLUBLE ANTIGEN EXTRACTED FROM PNEUMOCOCCI. J Exp Med. 1938 Apr 30;67(5):799–808. doi: 10.1084/jem.67.5.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hansen E. J., Robertson S. M., Gulig P. A., Frisch C. F., Haanes E. J. Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein. Lancet. 1982 Feb 13;1(8268):366–368. doi: 10.1016/s0140-6736(82)91394-0. [DOI] [PubMed] [Google Scholar]
  21. Kearney J. F., Barletta R., Quan Z. S., Quintáns J. Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice. Eur J Immunol. 1981 Nov;11(11):877–883. doi: 10.1002/eji.1830111106. [DOI] [PubMed] [Google Scholar]
  22. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979 Oct;123(4):1548–1550. [PubMed] [Google Scholar]
  23. Krause R. M. The search for antibodies with molecular uniformity. Adv Immunol. 1970;12:1–56. doi: 10.1016/s0065-2776(08)60167-4. [DOI] [PubMed] [Google Scholar]
  24. Macleod C. M., Hodges R. G., Heidelberger M., Bernhard W. G. PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES. J Exp Med. 1945 Nov 30;82(6):445–465. [PMC free article] [PubMed] [Google Scholar]
  25. Mold C., Nakayama S., Holzer T. J., Gewurz H., Du Clos T. W. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med. 1981 Nov 1;154(5):1703–1708. doi: 10.1084/jem.154.5.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SMITH R. T., EITZMAN D. V. THE DEVELOPMENT OF THE IMMUNE RESPONSE. CHARACTERIZATION OF THE RESPONSE OF THE HUMAN INFANT AND ADULT TO IMMUNIZATION WITH SALMONELLA VACCINES. Pediatrics. 1964 Feb;33:163–183. [PubMed] [Google Scholar]
  27. Sabin A. B. ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE. J Exp Med. 1931 Jan 1;53(1):93–107. doi: 10.1084/jem.53.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Saunders C. W., Guild W. R. Properties and transforming activities of two plasmids in Streptococcus pneumoniae. Mol Gen Genet. 1980;180(3):573–578. doi: 10.1007/BF00268062. [DOI] [PubMed] [Google Scholar]
  29. Scher I. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol. 1982;33:1–71. doi: 10.1016/s0065-2776(08)60834-2. [DOI] [PubMed] [Google Scholar]
  30. Stohrer R., Lee M. C., Kearney J. F. Analysis of the anti-alpha 1 leads to 3 dextran response with monoclonal anti-idiotype antibodies. J Immunol. 1983 Sep;131(3):1375–1379. [PubMed] [Google Scholar]
  31. Szu S. C., Clarke S., Robbins J. B. Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types. Infect Immun. 1983 Feb;39(2):993–999. doi: 10.1128/iai.39.2.993-999.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tillett W. S. ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI. J Exp Med. 1928 Nov 30;48(6):791–804. doi: 10.1084/jem.48.6.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yother J., Forman C., Gray B. M., Briles D. E. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody. Infect Immun. 1982 Apr;36(1):184–188. doi: 10.1128/iai.36.1.184-188.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Yother J., Volanakis J. E., Briles D. E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J Immunol. 1982 May;128(5):2374–2376. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES